Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD,

Published byHélène Larrivée Modified over 5 years ago

Similar presentations

Presentation on theme: "Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD,"— Presentation transcript:

1 Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD, PhD, Anders Bergqvist, PhD, Gabriel Thabut, MD, PhD, Marie-Christine Dombret, MD, Dominique Knapp, MS, Fatima Hamidi, MS, Loubna Alavoine, MD, Camille Taillé, MD, PhD, Pascal Chanez, MD, PhD, Jonas S. Erjefält, PhD, Michel Aubier, MD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 4, Pages (April 2017) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Histopathologic alterations induced by using BT. Bronchial biopsy specimens were assessed for immunohistochemical and morphometric analyses of ASM area (as a percentage of positive α-actin immunostained area over the submucosal tissue area; A), SBM thickening (in micrometers; B), submucosal blood (C) and lymphatic vessels (D), and submucosal nerve fibers (E) after immunolabeling of CD31, D2-40, and PGP9.5 antigens, respectively (all expressed as ‰ of positive immunostaining over the submucosal tissue area); of PGP9.5+ nerves infiltrating the ASM (in numbers per square millimeter of ASM; F); of mucous glands (as percentage of prevalence; G), eosinophils (H), and neutrophils (I) as proportions of bronchial mucosa with positive immunoreactivity for ECP and MPO, respectively (in percentages); of regenerating epithelium (as percentage prevalence; J); and of stratified columnar epithelium (as percentage prevalence; K), metaplastic epithelium (as percentage prevalence; L), squamous metaplastic epithelium (as percentage prevalence; M), goblet cell hypertrophy/hyperplasia (as percentage prevalence; N), and epithelial neuroendocrine (PGP9.5+) cells (in numbers per square millimeter of intact areas of bronchial epithelium; O). Comparisons were made by using the Student t test for paired values. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Structural effects of BT in bronchial biopsy specimens from patients with severe asthma. Bright-field micrographs of bronchial biopsy specimens subjected to quadruple immunohistochemical staining for smooth muscle actin (red), the vascular endothelial marker CD31 (green), lymph endothelial marker, podoplanin (D2-40, brown), and the neuronal marker PGP.9.5 (black) are shown. A and B, Biopsy specimens taken before and 3 months after BT, respectively (note that Fig 2, B, rather than representing the average, exemplifies a case in which smooth muscle was virtually absent). C, A neuroendocrine cell (NEC) in the bronchial epithelium detected based on nuclear distribution of PGP (arrowhead). D and E, Subepithelial nerves (arrowheads) in the subepithelial region before (Fig 2, D) and after (Fig 2, E) BT. F, Smooth muscle–associated nerves (arrowhead) exemplified in a biopsy specimen collected before BT treatment. Scale bars = 250 μm (Fig 2, A and B) or 40 μm (Fig 2, C-F). sm, Smooth muscle; bv, blood vessels; lv, lymphatic vessels. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Differences in histopathologic alterations in patients with BT-responsive and partially responsive severe asthma. ASM area (A), SBM thickening (B), submucosal PGP+ nerves (C), ASM-associated PGP+ nerves (D), and neuroendocrine epithelial PGP+ cells (E) in bronchial biopsy specimens from patients with severe asthma collected before (n = 15) and 3 months after BT are shown. Patients were separated into 2 groups according to their clinical responsiveness (n = 11, ACT score ≥ 15) or partial or no responsiveness (n = 4, ACT score < 15) to BT at 12 months. Overall P values were less than .01 (Fig 3, A), .31 (Fig 3, B), less than .01 (Fig 3, C), .06 (Fig 3, D), and less than .01 (Fig 3, E; Kruskal-Wallis test). *P < .05 compared with values obtained before BT and †P < .05 compared with patients responsive to BT, Student t test for paired values. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD,"

Similar presentations

Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.

Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor.
Are leukocytes in asthmatic patients aging faster

Are leukocytes in asthmatic patients aging faster
What effect does asthma treatment have on airway remodeling

What effect does asthma treatment have on airway remodeling
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.

Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.
Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD,

Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations  Marina Pretolani, PharmD,
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma  Makoto Hoshino, MDa, Yutaka Nakamura, MDa,

Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma  Makoto Hoshino, MDa, Yutaka Nakamura, MDa,
Fibrocyte localization to the airway smooth muscle is a feature of asthma  Ruth Saunders, PhD, Salman Siddiqui, MRCP, Davinder Kaur, PhD, Camille Doe,

Fibrocyte localization to the airway smooth muscle is a feature of asthma  Ruth Saunders, PhD, Salman Siddiqui, MRCP, Davinder Kaur, PhD, Camille Doe,
Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris,

Striking deposition of toxic eosinophil major basic protein in mucus: Implications for chronic rhinosinusitis  Jens U. Ponikau, MD, David A. Sherris,
Obstructive sleep apnea syndrome and inflammation

Obstructive sleep apnea syndrome and inflammation
Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome  Asger Sverrild, MD, PhD, Pia Kiilerich, MSc, PhD,

Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome  Asger Sverrild, MD, PhD, Pia Kiilerich, MSc, PhD,
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Airway epithelial cells in asthma

Airway epithelial cells in asthma
Increased TGF-β2 in severe asthma with eosinophilia

Increased TGF-β2 in severe asthma with eosinophilia
Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation 

Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation 
Calcitonin gene-related peptide– and vascular endothelial growth factor–positive inflammatory cells in late-phase allergic skin reactions in atopic subjects 

Calcitonin gene-related peptide– and vascular endothelial growth factor–positive inflammatory cells in late-phase allergic skin reactions in atopic subjects 
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Asthma therapy and airway remodeling

Asthma therapy and airway remodeling
IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells  Roua Al-Kufaidy, MS, Alejandro.

IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells  Roua Al-Kufaidy, MS, Alejandro.
Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.

Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses  Chris J. Corrigan, MD, PhD, Wei.

Similar presentations

Ads by Google